CASI Pharmaceuticals, Inc. - CASI
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 10
Latest filed: Mar 23, 2026
| Form | Count |
|---|---|
| 6-K | 5 |
| SCHEDULE 13D/A | 3 |
| SCHEDULE 13G/A | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Mar 23, 2026 | SCHEDULE 13D/A | — | 0001104659-26-032956 | View |
| Mar 03, 2026 | 6-K | Mar 03, 2026 | 0001104659-26-022579 | View |
| Feb 25, 2026 | 6-K | Feb 25, 2026 | 0001104659-26-019440 | View |
| Feb 20, 2026 | 6-K | Feb 20, 2026 | 0001104659-26-017895 | View |
| Feb 19, 2026 | 6-K | Feb 19, 2026 | 0001104659-26-017304 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001738048-26-000016 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | — | 0001104659-26-015415 | View |
| Feb 10, 2026 | SCHEDULE 13D/A | — | 0001104659-26-012278 | View |
| Feb 10, 2026 | 6-K | Feb 10, 2026 | 0001104659-26-012391 | View |
| Jan 29, 2026 | SCHEDULE 13D/A | — | 0001104659-26-008171 | View |